Cargando…
Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
Background: Lung cancer (LC) care is resource and cost intensive. We launched a Multidisciplinary LC Clinic (MDC), where patients with a new LC diagnosis received concurrent oncology consultation, resulting in improved time to LC assessment and treatment. Here, we evaluate the impact of MDC on healt...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161784/ https://www.ncbi.nlm.nih.gov/pubmed/33947127 http://dx.doi.org/10.3390/curroncol28030157 |
_version_ | 1783700575182913536 |
---|---|
author | Stone, Christopher J. L. Johnson, Ana P. Robinson, Danielle Katyukha, Andriy Egan, Rylan Linton, Sophia Parker, Christopher Robinson, Andrew Digby, Geneviève C. |
author_facet | Stone, Christopher J. L. Johnson, Ana P. Robinson, Danielle Katyukha, Andriy Egan, Rylan Linton, Sophia Parker, Christopher Robinson, Andrew Digby, Geneviève C. |
author_sort | Stone, Christopher J. L. |
collection | PubMed |
description | Background: Lung cancer (LC) care is resource and cost intensive. We launched a Multidisciplinary LC Clinic (MDC), where patients with a new LC diagnosis received concurrent oncology consultation, resulting in improved time to LC assessment and treatment. Here, we evaluate the impact of MDC on health resource utilization, patient and caregiver costs, and secondary patient benefits. Methods: We retrospectively analyzed patients in a rapid assessment clinic with a new LC diagnosis pre-MDC (September 2016–February 2017) and post-MDC implementation (February 2017–December 2018). Data are reported as means; unpaired t-tests and ANOVA were used to assess for significance. We also conducted a cost analysis. Resource utilization, out-of-pocket costs, procedure-related costs, and indirect costs were evaluated from the societal perspective and presented in 2019 Canadian dollars (CAD); multi-way worst/best case and threshold sensitivity analyses were conducted. Results: We reviewed 428 patients (78 traditional model, 350 MDC). Patients in the MDC model required significantly fewer oncology visits from LC diagnosis to first LC treatment (1.62 vs. 2.68, p < 0.001), which was significant for patients with stage 1, 3, and 4 disease. Compared with the traditional model, there was no change in mean biopsies/patient (1.32 traditional vs. 1.17 MDC, p = 0.18) or staging investigations/patient (2.24 traditional vs. 2.02 MDC, p = 0.20). Post-MDC, there was an increase in invasive mediastinal staging for patients with stage 2/3 LC (15.0% vs. 60.0%, p < 0.001). Over 22 months, MDC resulted in savings of CAD 48,389 including CAD 24,167 CAD in direct patient out-of-pocket expenses. For the threshold analyses, MDC was estimated to cost CAD 25,708 per quality-adjusted life year (QALY), considered to be below current willingness to pay thresholds (at CAD 80,000 per QALY). MDC also facilitated oncology assessment for 29 non-LC patients. Conclusions: An MDC led to a reduction in patient visits and direct patient and caregiver costs. |
format | Online Article Text |
id | pubmed-8161784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81617842021-05-29 Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic Stone, Christopher J. L. Johnson, Ana P. Robinson, Danielle Katyukha, Andriy Egan, Rylan Linton, Sophia Parker, Christopher Robinson, Andrew Digby, Geneviève C. Curr Oncol Article Background: Lung cancer (LC) care is resource and cost intensive. We launched a Multidisciplinary LC Clinic (MDC), where patients with a new LC diagnosis received concurrent oncology consultation, resulting in improved time to LC assessment and treatment. Here, we evaluate the impact of MDC on health resource utilization, patient and caregiver costs, and secondary patient benefits. Methods: We retrospectively analyzed patients in a rapid assessment clinic with a new LC diagnosis pre-MDC (September 2016–February 2017) and post-MDC implementation (February 2017–December 2018). Data are reported as means; unpaired t-tests and ANOVA were used to assess for significance. We also conducted a cost analysis. Resource utilization, out-of-pocket costs, procedure-related costs, and indirect costs were evaluated from the societal perspective and presented in 2019 Canadian dollars (CAD); multi-way worst/best case and threshold sensitivity analyses were conducted. Results: We reviewed 428 patients (78 traditional model, 350 MDC). Patients in the MDC model required significantly fewer oncology visits from LC diagnosis to first LC treatment (1.62 vs. 2.68, p < 0.001), which was significant for patients with stage 1, 3, and 4 disease. Compared with the traditional model, there was no change in mean biopsies/patient (1.32 traditional vs. 1.17 MDC, p = 0.18) or staging investigations/patient (2.24 traditional vs. 2.02 MDC, p = 0.20). Post-MDC, there was an increase in invasive mediastinal staging for patients with stage 2/3 LC (15.0% vs. 60.0%, p < 0.001). Over 22 months, MDC resulted in savings of CAD 48,389 including CAD 24,167 CAD in direct patient out-of-pocket expenses. For the threshold analyses, MDC was estimated to cost CAD 25,708 per quality-adjusted life year (QALY), considered to be below current willingness to pay thresholds (at CAD 80,000 per QALY). MDC also facilitated oncology assessment for 29 non-LC patients. Conclusions: An MDC led to a reduction in patient visits and direct patient and caregiver costs. MDPI 2021-04-29 /pmc/articles/PMC8161784/ /pubmed/33947127 http://dx.doi.org/10.3390/curroncol28030157 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stone, Christopher J. L. Johnson, Ana P. Robinson, Danielle Katyukha, Andriy Egan, Rylan Linton, Sophia Parker, Christopher Robinson, Andrew Digby, Geneviève C. Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic |
title | Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic |
title_full | Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic |
title_fullStr | Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic |
title_full_unstemmed | Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic |
title_short | Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic |
title_sort | health resource and cost savings achieved in a multidisciplinary lung cancer clinic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161784/ https://www.ncbi.nlm.nih.gov/pubmed/33947127 http://dx.doi.org/10.3390/curroncol28030157 |
work_keys_str_mv | AT stonechristopherjl healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT johnsonanap healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT robinsondanielle healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT katyukhaandriy healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT eganrylan healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT lintonsophia healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT parkerchristopher healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT robinsonandrew healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic AT digbygenevievec healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic |